Differences in age, p53 expression and outcome persisted when considering only intestinal-type carcinomas, as well as when tumours were stratified into three subtypes (proximal non-diffuse, diffuse, and distal non-diffuse) as suggested by Shah et al. [16] (Additional file 3: Table S3). The gene discussed is TP53; the disease is carcinoma.